They observed that differences in the levels of MITF and Interferon-gamma (IFN-γ) led to innate resistant melanoma cell subpopulations MITF (Extremelyhi) and MITF (low) cell subsets have two types of melanoma cells that present different characteristics and responses to therapy. The gene discussed is IFNG; the disease is melanoma.